Miner and maufacturer Rio Tinto will invest $215 million (US$143 million) to develop a research and development facility in Western Australia to assess the effectiveness of its low-carbon ironmaking process, BioIron, to support decarbonising the global steel value chain. The development of the BioIron Research and Development Facility in the Rockingham Strategic Industrial Area south…
Cyclopharm raises $20 million, seeks another $2 million Radiopharmaceutical imaging company Cyclopharm has successfully completed its institutional placement, raising $20 million before costs. The Placement attracted strong demand from both existing shareholders and from new institutional and sophisticated investors in Australia, Hong Kong, and the UK. A share purchase plan to raise up to $2.0…
BlueScope Steel and iron ore producers BHP and Rio Tinto have entered a partnership that could see the construction of a low emission Electric Smelting Facility (ESF) pilot plant which could cut carbon emissions in the steelmaking process by 80 percent. The ESF is capable of producing iron suitable for the basic oxygen steelmaking (BOS)…
